An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

247

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Major Depressive Disorder
Interventions
DRUG

Mifepristone

DRUG

placebo

Trial Locations (19)

Unknown

Georgy Koychev M.D., Sofia

Luchezar G Hranov M.D., Sofia

Svetlozar H Haralanov Ph.D., Sofia

Vihra Milanova M.D., Sofia

Georgi Popov M.D., Varna

Pavo Filakovic M.D./Ph.D., Osijek

Ljiljana Moro M.D./Ph.D., Rijeka

Goran Dodig M.D./Ph.D., Split

Dubravka Kocijan-Hercigonja M.D., Zagreb

Miro Jakovljevic M.D., Zagreb

Vera Folnegovic-Smalc M.D./Ph.D., Zagreb

Mihai Dumitru Gheorge, Bucharest

Aurel Nirestean M.D./Ph.D., Târgu Mureş

Ivana Timotijevic M.D., Belgrade

Jelena Martinovic M.D., Belgrade

Vladimir Diligenski M.D., Belgrade

Vladimir Paunovic M.D., Belgrade

Dragana Ignjatovic-Ristic M.D., Kragujevac

Ratomir Lisulov M.D., Novi Sad

Sponsors
All Listed Sponsors
lead

Corcept Therapeutics

INDUSTRY